TrialNanomedicine : nanotechnology, biology, and medicine2019

Phase I/II trial of nano-camptothecin CRLX101 with capecitabine and radiotherapy as neoadjuvant treatment for locally advanced rectal cancer.

Hanna K Sanoff et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.